Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effect of Vestibular Rehabilitation
This study is currently recruiting participants.
Verified by Norwegian University of Science and Technology, June 2008
Sponsors and Collaborators: Norwegian University of Science and Technology
Haukeland University Hospital
St. Olavs Hospital
Information provided by: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00702832
  Purpose

The aim of this study is to assess if early supported vestibular rehabilitation can reduce dizziness and improve daily life activities in patients with acute vestibular injury.

Our study question is:

Does early supported vestibular rehabilitation have an additional effect on dizziness symptoms and daily life functions compared to standard treatment?


Condition Intervention
Dizziness
Daily Life Activities
Balance
Behavioral: Vestibular rehabilitation

MedlinePlus related topics: Dizziness and Vertigo Rehabilitation
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Effects of Vestibular Rehabilitation in the Treatment of Patients With Acute Vestibular Loss. - A Randomized Controlled Trial

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Vertigo symptom scale [ Time Frame: at inclusion, 10-12 weeks, 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • - Dizziness Handicap Inventory - UCLA-DQ - HADS - VAS-scale on dizziness - Registration of provoked dizziness - Accelerometer - Sick leave - Adverse effects [ Time Frame: At inclusion, 10-12 weeks, 12 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: January 2008
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Vestibular rehabilitation
Behavioral: Vestibular rehabilitation
Daily home training (4-6 specific exercises) 2-3 times per day. Group training led by a physiotherapist twice per week during the first 10 weeks and once per week from 10 weeks to 12 months or to symptoms are cured.
2: No Intervention

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • acute symptoms of dizziness (vestibular injury)
  • diagnosed by videonystagmography
  • age 18-70 years
  • inclusion within one week after symptom debut

Exclusion Criteria:

  • chronic dizziness
  • psychiatric diagnosis that might interfere with participation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00702832

Contacts
Contact: Guri Tokle, Batchelor +47 72576292 guri.tokle@stolav.no
Contact: Siv Mørkved, PhD +47 73597584 siv.morkved@ntnu.no

Locations
Norway
St. Olavs Hospital Recruiting
Trondheim, Norway, 7489
Contact: Håkon Arnesen, Physician     +47 72575350     Haakon.Arnesen@stolav.no    
Contact: Siv Mørkved, PhD     +47 73597584     siv.morkved@ntnu.no    
Principal Investigator: Krister Brantberg, professor            
Sponsors and Collaborators
Norwegian University of Science and Technology
Haukeland University Hospital
St. Olavs Hospital
Investigators
Principal Investigator: Siv Mørkved, PhD Associate professor / senior researcher
  More Information

Responsible Party: st.Olavs hospital ( Siv Mørkved, Associate professor / Senior researcher )
Study ID Numbers: REK 4.2007.1802
Study First Received: June 19, 2008
Last Updated: June 19, 2008
ClinicalTrials.gov Identifier: NCT00702832  
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Vestibular rehabilitation, acute vestibular injury, dizziness, physiotherapy

Study placed in the following topic categories:
Signs and Symptoms
Sensation Disorders
Dizziness
Neurologic Manifestations

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 15, 2009